|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$128,455,406 |
|
|
Indirect Value
|
$40,265,984 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$168,721,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 21 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-02-17 |
4 |
B |
$0.82 |
$122,250 |
I/I |
150,000 |
46,562,000 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-02-18 |
4 |
B |
$0.82 |
$45,238 |
I/I |
55,000 |
46,617,000 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-09-28 |
4 |
B |
$0.84 |
$251 |
D/D |
300 |
15,993,117 |
2.37 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2019-12-19 |
4 |
B |
$0.85 |
$44,870 |
D/D |
52,788 |
7,924,000 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-20 |
4 |
B |
$0.85 |
$10,208 |
I/I |
12,000 |
46,412,000 |
2.17 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-09-29 |
4 |
B |
$0.87 |
$5,986 |
D/D |
6,883 |
16,000,000 |
3.84 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2019-01-10 |
4 |
S |
$0.88 |
$1,930,707 |
D/D |
(2,190,500) |
2,170,000 |
0 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2019-10-30 |
4 |
OE |
$0.88 |
$2,421,010 |
D/D |
2,751,148 |
7,871,212 |
0 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2019-12-20 |
4 |
B |
$0.88 |
$22,880 |
D/D |
26,000 |
7,950,000 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-18 |
4 |
B |
$0.88 |
$182,225 |
I/I |
206,300 |
46,306,300 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-19 |
4 |
B |
$0.88 |
$82,053 |
I/I |
93,700 |
46,400,000 |
2.25 |
% |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2018-08-20 |
4 |
S |
$0.91 |
$7,254 |
D/D |
(8,000) |
2,164,000 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-14 |
4 |
B |
$0.93 |
$78,974 |
I/I |
85,000 |
46,100,000 |
2.25 |
% |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2018-08-17 |
4 |
S |
$0.95 |
$45,682 |
D/D |
(48,000) |
2,172,000 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-11 |
4 |
B |
$0.96 |
$15,342 |
I/I |
16,003 |
45,645,000 |
2.17 |
% |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2020-03-10 |
4 |
S |
$0.99 |
$31,200,123 |
D/D |
(22,026,801) |
1 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-10 |
4 |
B |
$0.99 |
$484,615 |
I/I |
491,097 |
45,628,997 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-13 |
4 |
B |
$1.00 |
$314,013 |
I/I |
312,700 |
46,015,000 |
2.25 |
% |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2018-08-16 |
4 |
S |
$1.02 |
$1,222,200 |
D/D |
(1,200,000) |
2,220,000 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-07 |
4 |
B |
$1.04 |
$142,975 |
I/I |
137,900 |
45,137,900 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-12 |
4 |
B |
$1.04 |
$59,781 |
I/I |
57,300 |
45,702,300 |
2.25 |
% |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2018-06-13 |
4 |
B |
$1.07 |
$154,741 |
D/D |
145,297 |
2,970,897 |
2.45 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2017-10-16 |
4 |
B |
$1.08 |
$5,174 |
D/D |
4,800 |
16,004,800 |
3.84 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2018-06-12 |
4 |
B |
$1.08 |
$188,532 |
D/D |
156,895 |
2,825,600 |
2.45 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-06-29 |
4 |
OE |
$1.10 |
$4,500,000 |
D/D |
4,090,909 |
9,530,909 |
0 |
- |
|
790 Records found
|
|
Page 21 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|